High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
Rosa Bacchetta(The San Raffaele Telethon Institute for Gene Therapy), Maria‐Grazia Roncarolo(Regenerative Medicine Institute), Mike Bigler(Institut de Biologie Moléculaire et Cellulaire), Pier‐Angelo Tovo(Palo Alto Institute), J.L. Touraine(Palo Alto Institute), J S Abrams(Palo Alto Institute), René de Waal Malefyt(Merck & Co., Inc., Rahway, NJ, USA (United States)), J E de Vries, Robertson Parkman(Palo Alto Institute)
Cited by 408
Related Papers
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
|The Journal of Experimental Medicine|1996|774
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752
IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells
|The Journal of Immunology|2001|591